$254 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 8 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | Sell | KARUNA THERAPEUTICS INC | $97,200,000 | -11.0% | 852,708 | -6.2% | 38.31% | +9.3% |
| PCVX | VAXCYTE INC | $31,636,000 | +14.0% | 1,405,421 | 0.0% | 12.47% | +40.0% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $29,242,000 | -53.0% | 1,891,467 | 0.0% | 11.52% | -42.3% | |
| INZY | INOZYME PHARMA INC | $27,113,000 | -13.9% | 1,591,154 | 0.0% | 10.69% | +5.7% | |
| AKUS | AKOUOS INC | $22,516,000 | -9.5% | 1,794,088 | 0.0% | 8.87% | +11.2% | |
| ALGS | ALIGOS THERAPEUTICS INC | $17,873,000 | -10.3% | 876,548 | 0.0% | 7.04% | +10.1% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $15,529,000 | -5.7% | 569,041 | 0.0% | 6.12% | +15.9% | |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $12,613,000 | -26.4% | 1,598,377 | -0.0% | 4.97% | -9.6% |
| ETTX | Exit | ENTASIS THERAPEUTICS HLDGS I | $0 | – | -1,176,378 | -100.0% | -0.81% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
| VAXCYTE INC | 12 | Q3 2023 | 19.5% |
| INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
| ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
| FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
| ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
| RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
| AKOUOS INC | 8 | Q3 2022 | 11.7% |
| EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.